Skip to main content

Advertisement

Table 2 Mean values for quality of life sub-scales by systemic adjuvant treatment.*

From: Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49

  Chemotherapy + Hormonal Therapy
N = 59
Chemotherapy N = 59 Hormonal Therapy
N = 21
No Systemic Adjuvant Therapy
N = 76
P-value†
SF-36 sub scales
   Physical Functioning 75.6 78.7 85.5 84.5 .08
   Role Function-Physical 62.5 72.8 75.0 81.7 .02
   Bodily Pain 67.7 69.6 72.6 75.4 .10
   General Health 63.4 68.8 73.6 73.8 .05
   Vitality 47.4 54.6 51.5 56.3 .12
   Social Functioning 73.7 74.6 76.9 83.7 .01
   Role Function-Emotional 69.1 66.7 60.0 76.8 .07
   Mental Health 68.3 70.2 69.0 72.8 .16
SF-36 PCS 45.5 48.0 50.9 50.7 .05
SF-36 MCS 45.9 46.3 44.4 48.3 .14
CESD 13.1 11.7 12.0 10.8 .33
CARES-SF sub scales
   CARES Physical 0.6 0.6 0.5 0.3 <.01
   CARES Medical 0.4 0.6 0.3 0.4 .29
   CARES Psychosocial 0.7 0.8 0.7 0.6 .02
   CARES Sexual 1.8 1.8 1.2 1.0 <.01
   CARES Marital 0.7 0.8 0.4 0.4 .01
   CARES Global 0.7 0.7 0.6 0.5 <.01
  1. *Scoring: SF-36 subscales 0 to 100 with higher scores indicating higher QOL; CESD 0 to 60 with higher score indicating more depressive symptoms; CARES-SF 0–4 with higher score indicating more difficulty or impairment. † P value is for the comparison of women who received any adjuvant therapy to those who received no adjuvant therapy based on ANOVA.